Celcuity Inc
CELCToday
-5.15%
5 Days
-5.44%
1 Month
+6.22%
6 Months
-20.83%
Year to Date
-11.33%
1 Year
+72.63%
Recent
Transcripts
Bristol-Myers Squibb Co Stock (BMY) Closed Up by 3.12% on Jul 15: Key Drivers Unveiled
• Bristol Myers Squibb rose due to positive late-stage clinical trial results. • Increased institutional inflows support the company's defensive pharmaceutical sector valuation. • Technical indicators show a breakout, with a current MACD value of 0.322.
Novo Nordisk A/S Stock (NVO) Closed Up by 3.02% on Jul 15: Drivers Behind the Movement
• Novo Nordisk shares rose on manufacturing expansion and obesity treatment clinical milestones. • Semaglutide therapeutic expansion into kidney disease and metabolic conditions attracted institutional capital. • Robust free cash flow and market dominance provide stability amid broader economic uncertainty.
Merck & Co Inc Stock (MRK) Moved Up by 3.05% on Jul 15: Key Drivers Unveiled
• Merck shares rose following positive oncology clinical data and robust pipeline developments. • Diversified growth in cardiovascular and immunology segments supports long-term revenue expectations. • Analysts revised forecasts upward, citing improved operational margins and disciplined capital allocation.
Celcuity Inc's Score
Media Coverage
Analyst Rating
Celcuity Inc Technical Analysis
Technical Indicators
Summary
Moving Average
Celcuity Inc Latest Earnings Call Transcripts
Celcuity (CELC) Q2 2026 Earnings Call: REVTORPYK Launch Set for Late Q3
Financial Indicators
Earnings
Celcuity Inc Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Baker Bros. Advisors LP | 16.38% |
| Perceptive Advisors LLC | 6.54% |
| Sullivan (Brian F) | 6.46% |
| Avoro Capital Advisors LLC | 6.44% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 33.92% |
| Investment Advisor | 23.78% |
| Investment Advisor/Hedge Fund | 19.70% |
| Individual Investor | 9.48% |
Related Instruments
Popular Instruments
